& da Silva Junior, P
Ultimately, a patients preference for a certain type of device may vary and should also be taken into account
For someone in the 33% marginal tax bracket paying $20,000 annually for Retatrutide: Total medication cost: $20,000 Minus 3% of net income: $20,000 $2,100 = $17,900 deductible Tax savings at 33% bracket: $17,900 0.33 = $5,907 Net cost after tax deduction: $20,000 $5,907 = $14,093 Thats a 29.5% reduction in real cost
My Playbook for LDN Success Through years of practice, Ive found Low Dose Naltrexone shows particular promise for patients with 22 : Autoimmune conditions (rheumatoid arthritis, multiple sclerosis, Crohns disease, Hashimotos) Chronic pain syndromes (fibromyalgia, chronic fatigue syndrome) Post-viral conditions (Long COVID, post-viral fatigue) Complex chronic illness not responding to conventional approaches These are the patients I see most in functional medicinepeople the conventional system has failed or dismissed
Those diversions disable current customs and regulatory oversight, blinding officials to the true supply chain concentration risks, while funneling multiple nominally independent supply lines through a handful of southeastern U.S
Instead, Eden facilitates secure access to licensed professionals who may prescribe compounded topical formulations that include GHK-Cu
